You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
紅日藥業(300026.SZ)業績快報:2021年度淨利升20.03%至6.88億元
格隆匯 02-28 11:55

格隆匯2月28日丨紅日藥業(300026.SZ)披露2021年度業績快報,報吿期內,公司實現營業總收入77.41億元,同比增長19.32%;營業利潤8.78億元,同比增長34.18%;利潤總額8.57億元,同比增長25.36%;歸屬於上市公司股東的淨利潤6.88億元,同比增長20.03%;基本每股收益0.23元。

報吿期內,公司加強資源配置和業務協同,積極佈局和把握市場機遇,延續了良好的經營態勢,其中中藥配方顆粒業務,繼續加強全國產能佈局,持續提升市場覆蓋率和存量市場的滲透率,收入及利潤較上年同期取得較大增長;成品藥業務,主力產品血必淨注射液銷售量穩步增長;原輔料藥業務,受益於國際醫藥產業鏈重構,公司把握市場機遇,積極推進產品優化,促進海外市場份額提升,營業收入較上年同期有一定的增長。

同時,報吿期內,公司面向專業投資者公開發行公司債券(第一期)6億元,進一步優化融資結構,拓寬融資渠道,合理控制融資成本。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account